Authors: Wang-Gohrke, S Chang-Claude, J

Citation: S. Wang-gohrke et J. Chang-claude, Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk, J NAT CANC, 93(21), 2001, pp. 1657-1658

Authors: Bruning, A Kohler, T Quist, S Wang-Gohrke, S Moebus, VJ Kreienberg, R Runnebaum, IB

Citation: A. Bruning et al., Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta(3) subunit expression and increased by reconstitution of integrin alpha(V)beta(3), HUM GENE TH, 12(4), 2001, pp. 391-399

Authors: Runnebaum, IB Wang-Gohrke, S Vesprini, D Kreienberg, R Lynch, H Moslehi, R Ghadirian, P Weber, B Godwin, AK Risch, H Garber, J Lerman, C Olopade, OI Foulkes, WD Karlan, B Warner, E Rosen, B Rebbeck, T Tonin, P Dube, MP Kieback, DG Narod, SA

Citation: Ib. Runnebaum et al., Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives, PHARMACOGEN, 11(7), 2001, pp. 635-638

Authors: Wang-Gohrke, S Chang-Claude, J Becher, H Kieback, DG Runnebaum, IB

Citation: S. Wang-gohrke et al., Progesterone receptor gene polymorphism is associated with decreased risk for breast cancer by age 50, CANCER RES, 60(9), 2000, pp. 2348-2350

Authors: Runnebaum, IB Wang-Gohrke, S

Citation: Ib. Runnebaum et S. Wang-gohrke, Multiplex PCR (MPCR) screening can detect small intragenic p53 deletion and insertion mutations, METH MOL M, 39, 2000, pp. 329-335

Authors: Wang-Gohrke, S Weikel, W Risch, H Vesprini, D Abrahamson, J Lerman, C Godwin, A Moslehi, R Olipade, O Brunet, JS Stickeler, E Kieback, DG Kreienberg, R Weber, B Narod, SA Runnebaum, IB

Citation: S. Wang-gohrke et al., Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutations, BR J CANC, 81(1), 1999, pp. 179-183